Richard P. Denness Net Worth

The estimated Net Worth of Richard Denness is at least $2.57 Million dollars as of 1 August 2020. Mr Denness owns over 33,005 units of Option Care Health stock worth over $2,196,062 and over the last 6 years he sold OPCH stock worth over $0. In addition, he makes $376,445 as Chief Commercial Officer at Option Care Health.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Denness OPCH stock SEC Form 4 insiders trading

Mr has made over 2 trades of the Option Care Health stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 33,005 units of OPCH stock worth $1,070,352 on 1 August 2020.

The largest trade he's ever made was exercising 33,005 units of Option Care Health stock on 1 August 2020 worth over $1,070,352. On average, Mr trades about 5,195 units every 37 days since 2018. As of 1 August 2020 he still owns at least 67,717 units of Option Care Health stock.

You can see the complete history of Mr Denness stock trades at the bottom of the page.

Mr. Richard P. Denness biography

Richard P. Denness is the Chief Commercial Officer at Option Care Health.

What is the salary of Mr Denness?

As the Chief Commercial Officer of Option Care Health, the total compensation of Mr Denness at Option Care Health is $376,445. There are 9 executives at Option Care Health getting paid more, with Harriet Booker having the highest compensation of $1,393,652.

How old is Mr Denness?

Mr Denness is 54, he's been the Chief Commercial Officer of Option Care Health since . There are 9 older and 9 younger executives at Option Care Health. The oldest executive at Option Care Health, Inc. is John Arlotta, 70, who is the Independent Director.

What's Mr Denness's mailing address?

Richard's mailing address filed with the SEC is C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN, IL, 60015.

Insiders trading at Option Care Health

Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten, and Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.

What does Option Care Health do?

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Complete history of Mr Denness stock trades at Option Care Health

Option Care Health executives and stock owners

Option Care Health executives and other stock owners filed with the SEC include:

• Harriet Booker,
  Chief Operating Officer
• Harriet Booker,
  Chief Operating Officer
• Rich Denness,
  Chief Strategy Officer
• John Rademacher,
  Chief Executive Officer, Director
• John C. Rademacher,
  CEO, Pres & Director
• Michael Shapiro,
  Chief Financial Officer
• Michael H. Shapiro,
  CFO & Sr. VP
• R. Carter Pate,
  Independent Director
• Clifford Berman,
  General Counsel
• Richard P. Denness,
  Chief Commercial Officer
• Clifford E. Berman,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Harry Jansen Kraemer,
  Independent Non-Executive Chairman of the Board
• David Golding,
  Independent Director
• John Arlotta,
  Independent Director
• Nitin Sahney,
  Independent Director
• Timothy Sullivan,
  Director
• Elizabeth Betten,
  Director
• Mark Vainisi,
  Director
• Alan Nielsen,
  Director
• Christopher Hartman,
  Chief Growth Officer
• Luke Whitworth,
  Sr. VP of Revenue Cycle Management
• Julie Koenig,
  Sr. VP of Operations
• Christopher Frederick Hartman,
  Chief Growth Officer
• Matthew Deans,
  Sr. VP of Bus. Devel.
• Michael W. Rude,
  Sr. VP & Chief HR Officer
• Cari Reed,
  Sr. VP & Chief Compliance Officer
• Brett Michalak,
  Chief Information Officer
• Robert R. Kampstra,
  Sr. VP of Fin. & Chief Accounting Officer
• Femi Adewunmi,
  Chief Medical Officer
• Barbara W. Bodem,
  Director
• Norman L. Wright,
  Director
• Boots Alliance, Inc.Och Us ...,
  
• Dearborn Partners Llcmadiso...,
  
• Dearborn Capital Partners V...,
  
• Elizabeth D Bierbower,
  Director
• Collin Smyser,
  GC & Corporate Secretary
• Natasha Deckmann,
  Director
• Seema Kumbhat,
  Chief Medical Officer
• Dearborn Partners Llcmadiso...,
  
• Robert R Kampstra,
  CHIEF ACCOUNTING OFFICER
• Dearborn Partners Llcmadiso...,
  
• Luke Whitworth,
  Chief Operating Officer
• Michael Bavaro,
  Chief Human Resources Officer
• Christopher L. Grashoff,
  Chief Growth Officer
• Eric Brandt,
  Director